Latest Autoimmunity Stories
SAN DIEGO, July 14, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise announced today, the scientific publication of a splice variant of a tRNA synthetase
New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.
Researchers have developed an inexpensive and portable new device that uses nanotechnology to diagnose type-1 diabetes – a breakthrough that they claim could improve patient care worldwide and help medical experts better understand the condition.
A number of studies suggest that children delivered by Caesarean section have a different intestinal flora than children delivered by natural birth.
Strengthens Collaboration between the Nation's Lupus Research Organizations NEW YORK, July 8, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) today announced that Team
The Autoimmunity Bible & Norton Protocol is a new product created by Julia Liu and is a system designed for people suffering from and wanting to cure for good their autoimmune disorders.
More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5.
MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of
NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a
CHICAGO, June 25, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of the University of Michigan, was honored Wednesday as the second recipient of the Lupus Insight Prize,
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.